190 related articles for article (PubMed ID: 36359879)
21. Prognostic value of leukemia inhibitory factor and its receptor in pancreatic adenocarcinoma.
Wang D; Liu K; Yang Y; Wang T; Rao Q; Guo W; Zhang Z
Future Oncol; 2020 Jan; 16(3):4461-4473. PubMed ID: 31854204
[TBL] [Abstract][Full Text] [Related]
22. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
[TBL] [Abstract][Full Text] [Related]
23. Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling.
Fairlie WD; Uboldi AD; McCoubrie JE; Wang CC; Lee EF; Yao S; De Souza DP; Mifsud S; Metcalf D; Nicola NA; Norton RS; Baca M
J Biol Chem; 2004 Jan; 279(3):2125-34. PubMed ID: 14585833
[TBL] [Abstract][Full Text] [Related]
24. The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.
Spencer N; Rodriguez Sanchez AL; Gopalam R; Subbarayalu P; Medina DM; Yang X; Ramirez P; Randolph L; Aller EJ; Santhamma B; Rao MK; Tekmal RR; Nair HB; Kost ER; Vadlamudi RK; Viswanadhapalli S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139260
[TBL] [Abstract][Full Text] [Related]
25. Association of novel stop-gained leukaemia inhibitory factor receptor gene (rs121912501) variant, leukaemia inhibitory factor and ovarian steroids with unexplained infertility among Pakistani women.
Ali R; Iqbal MUN; Rehman R; Khan TA
Int J Clin Pract; 2021 Jul; 75(7):e14245. PubMed ID: 33914392
[TBL] [Abstract][Full Text] [Related]
26. Expression of leukemia inhibitory factor and leukemia inhibitory factor receptor in the canine pituitary gland and corticotrope adenomas.
Hanson JM; Mol JA; Meij BP
Domest Anim Endocrinol; 2010 May; 38(4):260-71. PubMed ID: 20036483
[TBL] [Abstract][Full Text] [Related]
27. EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer.
Viswanadhapalli S; Luo Y; Sareddy GR; Santhamma B; Zhou M; Li M; Ma S; Sonavane R; Pratap UP; Altwegg KA; Li X; Chang A; Chávez-Riveros A; Dileep KV; Zhang KYJ; Pan X; Murali R; Bajda M; Raj GV; Brenner AJ; Manthati V; Rao MK; Tekmal RR; Nair HB; Nickisch KJ; Vadlamudi RK
Mol Cancer Ther; 2019 Aug; 18(8):1341-1354. PubMed ID: 31142661
[TBL] [Abstract][Full Text] [Related]
28. Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations.
Kosfeld A; Brand F; Weiss AC; Kreuzer M; Goerk M; Martens H; Schubert S; Schäfer AK; Riehmer V; Hennies I; Bräsen JH; Pape L; Amann K; Krogvold L; Bjerre A; Daniel C; Kispert A; Haffner D; Weber RG
Hum Mol Genet; 2017 May; 26(9):1716-1731. PubMed ID: 28334964
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of leukemia inhibitory factor receptor (LIFR) and leukemia inhibitory factor (LIF) is associated with tubal pregnancy occurrence.
Li Y; Sun L; Zhao D; Ouyang J; Xiang M
Turk J Med Sci; 2015; 45(1):214-20. PubMed ID: 25790555
[TBL] [Abstract][Full Text] [Related]
30. Effects of Leukaemia Inhibitory Factor Receptor on the Early Stage of Osteogenic Differentiation of Human Bone Marrow Mesenchymal Cells.
Wang T; Yan RQ; Xu XY; Cao LL; Liu JY; Zheng MR; Li WD
Folia Biol (Praha); 2018; 64(5-6):186-194. PubMed ID: 30938676
[TBL] [Abstract][Full Text] [Related]
31. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
32. Regulation of neurokine receptor signaling and trafficking.
Nathanson NM
Neurochem Int; 2012 Nov; 61(6):874-8. PubMed ID: 22306348
[TBL] [Abstract][Full Text] [Related]
33. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition.
Ramaker RC; Hardigan AA; Gordon ER; Wright CA; Myers RM; Cooper SJ
BMC Cancer; 2021 May; 21(1):632. PubMed ID: 34049503
[TBL] [Abstract][Full Text] [Related]
34. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors.
Metz S; Naeth G; Heinrich PC; Müller-Newen G
J Biol Chem; 2008 Mar; 283(10):5985-95. PubMed ID: 18174171
[TBL] [Abstract][Full Text] [Related]
35. Mifepristone regulation of leukemia inhibitory factor and uterine receptivity in rabbits.
Liu CQ; Yuan Y; Wang ZX; Lu SH
Contraception; 1999 Nov; 60(5):309-12. PubMed ID: 10717784
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
[TBL] [Abstract][Full Text] [Related]
37. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD
PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920
[TBL] [Abstract][Full Text] [Related]
38. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
Yang S; He P; Wang J; Schetter A; Tang W; Funamizu N; Yanaga K; Uwagawa T; Satoskar AR; Gaedcke J; Bernhardt M; Ghadimi BM; Gaida MM; Bergmann F; Werner J; Ried T; Hanna N; Alexander HR; Hussain SP
Cancer Res; 2016 Jul; 76(13):3838-50. PubMed ID: 27197190
[TBL] [Abstract][Full Text] [Related]
39. Cross-reactivity of two human IL-6 family cytokines OSM and LIF explored by protein-protein docking and molecular dynamics simulation.
Du Q; Qian Y; Xue W
Biochim Biophys Acta Gen Subj; 2021 Jul; 1865(7):129907. PubMed ID: 33845142
[TBL] [Abstract][Full Text] [Related]
40. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
